Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ropivacaine extended release - Encore/PainReform

Next Previous
X
Search
Drug Profile

Ropivacaine extended release - Encore/PainReform

Alternative Names: ETI-211 - Encore; F-93; LNP-oily solution; LNP-oily solution (Ropivacaine); PRF-108

Latest Information Update: 31 Dec 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Encore Therapeutics
  • Class Anilides; Local anaesthetics; Non-opioid analgesics; Piperidines; Small molecules
  • Mechanism of Action Potassium channel antagonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Postoperative pain

Most Recent Events

  • 06 Jan 2016 No development reported - Phase-I/II for Postoperative pain in Israel (SC)
  • 26 Sep 2011 Ropivacaine depot is available for licensing as of 26 Sep 2011
  • 06 Apr 2011 Preclinical development is ongoing in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top